| 发明名称 | Phoenixin peptides | ||
| 摘要 | Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying. | ||
| 申请公布号 | US9018350(B2) | 申请公布日期 | 2015.04.28 |
| 申请号 | US201214119866 | 申请日期 | 2012.05.25 |
| 申请人 | Phoenix Pharmaceuticals, Inc. | 发明人 | Chang Jaw-Kang;Lyu Rong-Ming |
| 分类号 | C07K7/08;C07K14/575;C07K14/705;A61K38/00 | 主分类号 | C07K7/08 |
| 代理机构 | CR Miles, P.C. | 代理人 | Miles Craig R.;CR Miles, P.C. |
| 主权项 | 1. A purified and isolated polypeptide consisting of the amino acid sequence selected from the group consisting of SEQ ID NOS: 2 through 60, wherein said purified and isolated polypeptide includes one or more of the following modifications: a substitution of an L form amino acid residue with a D form amino acid residue, an amide C-terminus, and an acetyl N-terminus. | ||
| 地址 | Burlingame CA US | ||